This Article  • References  • Full text PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

William Matuzas, MD; Richard M. Glass, MD

Arch Gen Psychiatry. 1983;40(2):220-222.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

A number of double-blind placebo-controlled studies have demonstrated the efficacy of imipramine hydrochloride^1-4 and phenelzine sulfate^4-7 in the treatment of phobic disorders, particularly agoraphobia associated with panic attacks. Uncontrolled clinical observations suggest that other "antidepressants" may also be effective. In this issue of the ARCHIVES, Zitrin and her New York colleagues present the final results of a study of the treatment of patients with phobic disorders (see p 125). Their study was started in 1972 and described in a preliminary report in this journal.² Marks and his British colleagues also present in this issue results of a similar investigation, but they arrive at quite different conclusions (see p 153). Briefly, the New York group concludes that imipramine is effective in the treatment of phobic patients with panic attacks. Furthermore, dynamically oriented supportive psychotherapy is as effective as behavior therapy, as long as both lead to confrontation with . . . [Full Text PDF of this Article]

Author Affiliations
From the Department of Psychiatry, University of Chicago.

Footnotes
Accepted for publication Nov 4, 1982.

Reprint requests to Department of Psychiatry, University of Chicago, 950 E 59th St, Chicago, IL 60637 (Dr Matuzas).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?